Schroder Investment Management Group Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Schroder Investment Management Group

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $337,733 - $354,835	2,330 Added 3.39%	71,140 $10.8 Million
Q2 2022 Aug 11, 2022	BUY	$83.14 - $145.99 $123,546 - $216,941	1,486 Added 2.21%	68,810 $10 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $2.46 Million - $3.19 Million	22,339 Added 49.66%	67,324 $7.95 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $1.98 Million - $2.95 Million	-19,856 Reduced 30.62%	44,985 $6.2 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $926,619 - $1.3 Million	-9,374 Reduced 12.63%	64,841 $9.01 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $1.33 Million - $2.13 Million	20,287 Added 37.62%	74,215 $7.21 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $595,658 - $852,999	9,297 Added 20.83%	53,928 $3.69 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $454,318 - $685,911	-6,982 Reduced 13.53%	44,631 $3.83 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $257,119 - $339,472	4,355 Added 9.22%	51,613 $3.36 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $674,424 - $1.73 Million	23,248 Added 96.83%	47,258 $3.46 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $176,779 - $368,145	-6,426 Reduced 21.11%	24,010 $770,000
Q4 2019 Feb 11, 2020	BUY	$40.86 - $57.65 $1.24 Million - $1.75 Million	30,436 New	30,436 $1.66 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.